Century Therapeutics (IPSC)
(Delayed Data from NSDQ)
$1.96 USD
-0.13 (-6.22%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $1.95 -0.01 (-0.51%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/14/24 |
---|---|
Current Quarter | -0.50 |
EPS Last Quarter | -0.45 |
Last EPS Surprise | 10.00% |
ABR | 1.29 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.94 |
Next Year | -1.97 |
EPS (TTM) | -2.05 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.55M | 0.55M | 9.32M | 13.41M |
# of Estimates | 2 | 2 | 4 | 4 |
High Estimate | 1.00M | 1.00M | 30.97M | 44.25M |
Low Estimate | 0.10M | 0.10M | 1.16M | 0.40M |
Year ago Sales | 0.10M | 0.15M | 2.23M | 9.32M |
Year over Year Growth Est. | 450.00% | 266.67% | 317.09% | 43.87% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.50 | -0.51 | -1.94 | -1.97 |
# of Estimates | 3 | 3 | 4 | 4 |
Most Recent Consensus | -0.51 | -0.52 | -1.75 | -1.42 |
High Estimate | -0.38 | -0.38 | -1.61 | -1.42 |
Low Estimate | -0.61 | -0.64 | -2.37 | -2.54 |
Year ago EPS | -0.56 | -0.55 | -2.08 | -1.94 |
Year over Year Growth Est. | 10.71% | 7.27% | 6.73% | -1.68% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.50 | -0.51 | -1.94 | -1.97 |
7 Days Ago | -0.50 | -0.51 | -1.94 | -1.97 |
30 Days Ago | -0.50 | -0.51 | -1.94 | -1.97 |
60 Days Ago | -0.50 | -0.51 | -1.94 | -1.97 |
90 Days Ago | -0.49 | -0.49 | -1.94 | -2.00 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.50 | -0.51 | -1.94 | -1.97 |
Zacks Consensus Estimate | -0.50 | -0.51 | -1.94 | -1.97 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.45 | -0.49 | -0.55 | -0.56 | NA |
Estimate | -0.50 | -0.56 | -0.53 | -0.54 | NA |
Difference | 0.05 | 0.07 | -0.02 | -0.02 | 0.02 |
Surprise | 10.00% | 12.50% | -3.77% | -3.70% | 3.76% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more